111 related articles for article (PubMed ID: 3495529)
1. The effects of inhibitors of sulphur-containing amino acid metabolism on the growth of Trichomonas vaginalis in vitro.
Thong KW; Coombs GH
J Antimicrob Chemother; 1987 Apr; 19(4):429-37. PubMed ID: 3495529
[TBL] [Abstract][Full Text] [Related]
2. In vitro inhibition of Giardia lamblia and Trichomonas vaginalis growth by bithionol, dichlorophene, and hexachlorophene.
Takeuchi T; Kobayashi S; Tanabe M; Fujiwara T
Antimicrob Agents Chemother; 1985 Jan; 27(1):65-70. PubMed ID: 3872626
[TBL] [Abstract][Full Text] [Related]
3. Pentamycin shows high efficacy against Trichomonas vaginalis.
Kranzler M; Syrowatka M; Leitsch D; Winnips C; Walochnik J
Int J Antimicrob Agents; 2015 Apr; 45(4):434-7. PubMed ID: 25703311
[TBL] [Abstract][Full Text] [Related]
4. In vitro effect of octenidine dihydrochloride against Trichomonas vaginalis.
Küng E; Pietrzak J; Klaus C; Walochnik J
Int J Antimicrob Agents; 2016 Mar; 47(3):232-4. PubMed ID: 26899578
[TBL] [Abstract][Full Text] [Related]
5. Antiparasitic activity of furanyl N-acylhydrazone derivatives against Trichomonas vaginalis: in vitro and in silico analyses.
Alves MSD; das Neves RN; Sena-Lopes Â; Domingues M; Casaril AM; Segatto NV; Nogueira TCM; de Souza MVN; Savegnago L; Seixas FK; Collares T; Borsuk S
Parasit Vectors; 2020 Feb; 13(1):59. PubMed ID: 32046788
[TBL] [Abstract][Full Text] [Related]
6. Trichomonas species: homocysteine desulphurase and serine sulphydrase activities.
Thong KW; Coombs GH
Exp Parasitol; 1987 Apr; 63(2):143-51. PubMed ID: 3494628
[TBL] [Abstract][Full Text] [Related]
7. Auranofin inactivates Trichomonas vaginalis thioredoxin reductase and is effective against trichomonads in vitro and in vivo.
Hopper M; Yun JF; Zhou B; Le C; Kehoe K; Le R; Hill R; Jongeward G; Debnath A; Zhang L; Miyamoto Y; Eckmann L; Land KM; Wrischnik LA
Int J Antimicrob Agents; 2016 Dec; 48(6):690-694. PubMed ID: 27839893
[TBL] [Abstract][Full Text] [Related]
8. Eicosapentaenoic Acid Modulates Trichomonas vaginalis Activity.
Korosh T; Jordan KD; Wu JS; Yarlett N; Upmacis RK
J Eukaryot Microbiol; 2016; 63(2):153-61. PubMed ID: 26333486
[TBL] [Abstract][Full Text] [Related]
9. Effect of the antimicrobial peptide tritrpticin on the in vitro viability and growth of Trichomonas vaginalis.
Infante VV; Miranda-Olvera AD; De Leon-Rodriguez LM; Anaya-Velazquez F; Rodriguez MC; Avila EE
Curr Microbiol; 2011 Jan; 62(1):301-6. PubMed ID: 20640424
[TBL] [Abstract][Full Text] [Related]
10. Current therapeutics, their problems, and sulfur-containing-amino-acid metabolism as a novel target against infections by "amitochondriate" protozoan parasites.
Ali V; Nozaki T
Clin Microbiol Rev; 2007 Jan; 20(1):164-87. PubMed ID: 17223627
[TBL] [Abstract][Full Text] [Related]
11. Drug library screening against metronidazole-sensitive and metronidazole-resistant Trichomonas vaginalis isolates.
Goodhew EB; Secor WE
Sex Transm Infect; 2013 Sep; 89(6):479-84. PubMed ID: 23794105
[TBL] [Abstract][Full Text] [Related]
12.
Ghosh AP; Aycock C; Schwebke JR
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29439963
[TBL] [Abstract][Full Text] [Related]
13. Validation of novel fluorescence assays for the routine screening of drug susceptibilities of Trichomonas vaginalis.
Natto MJ; Savioli F; Quashie NB; Dardonville C; Rodenko B; de Koning HP
J Antimicrob Chemother; 2012 Apr; 67(4):933-43. PubMed ID: 22258922
[TBL] [Abstract][Full Text] [Related]
14. Trichomonas vaginalis prevalence, incidence, risk factors and antibiotic-resistance in an adolescent population.
Krashin JW; Koumans EH; Bradshaw-Sydnor AC; Braxton JR; Evan Secor W; Sawyer MK; Markowitz LE
Sex Transm Dis; 2010 Jul; 37(7):440-4. PubMed ID: 20351623
[TBL] [Abstract][Full Text] [Related]
15. Potential of bisbenzimidazole-analogs toward metronidazole-resistant Trichomonas vaginalis isolates.
Korosh T; Bujans E; Morada M; Karaalioglu C; Vanden Eynde JJ; Mayence A; Huang TL; Yarlett N
Chem Biol Drug Des; 2017 Oct; 90(4):489-495. PubMed ID: 28296056
[TBL] [Abstract][Full Text] [Related]
16. In vitro anti-Trichomonas vaginalis activity of Haplophyllum myrtifolium.
Gokmen AA; Can H; Kayalar H; Pektaş B; Kaya S
J Infect Dev Ctries; 2019 Mar; 13(3):240-244. PubMed ID: 32040454
[TBL] [Abstract][Full Text] [Related]
17. Biological variability of Trichomonas vaginalis clinical isolates from symptomatic and asymptomatic patients.
Hussien EM; El-Sayed HZ; Shaban MM; Salm AM; Rashwan M
J Egypt Soc Parasitol; 2004 Dec; 34(3):979-88. PubMed ID: 15587322
[TBL] [Abstract][Full Text] [Related]
18. Amaurocine: Anti-Trichomonas vaginalis protein produced by the basidiomycete Amauroderma camerarium.
Duarte M; Seixas A; Peres de Carvalho M; Tasca T; Macedo AJ
Exp Parasitol; 2016 Feb; 161():6-11. PubMed ID: 26706604
[TBL] [Abstract][Full Text] [Related]
19. Effect of Mexican medicinal plant used to treat trichomoniasis on Trichomonas vaginalis trophozoites.
Calzada F; Yépez-Mulia L; Tapia-Contreras A
J Ethnopharmacol; 2007 Sep; 113(2):248-51. PubMed ID: 17628366
[TBL] [Abstract][Full Text] [Related]
20. [In vitro susceptibility of Trichomonas vaginalis to metronidazole, ornidazole and proton pump inhibitors pantoprazole and esomeprazole].
Aksoy Gökmen A; Girginkardeşler N; Kilimcioğlu AA; Şirin MC; Özbilgin A
Mikrobiyol Bul; 2016 Jan; 50(1):133-9. PubMed ID: 27058337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
